Search

BENTHAM INSIGHT

An insight to Bentham Science Publishers

New Issue ::: Current Hypertension Reviews 12, Issue 2

Current Hypertension Reviews publishes frontier reviews, original research articles and guest edited thematic issues on all the latest advances on hypertension and its related areas e.g. nephrology, clinical care, and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians and researchers in the field of hypertension.

p

Articles from the journal Current Hypertension Reviews, Volume 12, Issue 2:

 

 

For details on the articles, please visit this link :: http://bit.ly/29YLaYr

New Issue ::: Central Nervous System Agents in Medicinal Chemistry 16, Issue 2

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Containing a series of timely in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics, Central Nervous System Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.

p

Articles from the journal Central Nervous System Agents in Medicinal Chemistry, Volume 16, Issue 2:

 

 

For details on the articles, please visit this link :: http://bit.ly/2avYW5F

Testimonial by Dr. Robert M. Handler!

test 3

Dr. Robert M. Handler

Contributed Article: “Life-Cycle Assessment of Algae Renewable Diesel: Influence of Alternative Uses for Lipid-Extracted Algae”

New Issue ::: Current Pharmaceutical Analysis 12, Issue 3

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

p

Articles from the journal Current Pharmaceutical Analysis, Volume 12, Issue 3:

 

For details on the articles, please visit this link :: http://bit.ly/2aaKBfD

New Issue ::: Current Alzheimer Research 13, Issue 8

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

NEW ISSUE 3

Articles from the journal Current Alzheimer Research, Volume 13, Issue 8:

For details on the articles, please visit this link :: http://bit.ly/2auH77b

New Issue ::: Current Medical Imaging Reviews 12, Issue 3

Current Medical Imaging Reviews publishes frontier review articles, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances on medical imaging dedicated to clinical research. All relevant areas are covered by the journal, including advances in the diagnosis, instrumentation and therapeutic applications related to all modern medical imaging techniques.

The journal is essential reading for all clinicians and researchers involved in medical imaging and diagnosis.

p

Articles from the journal Current Medical Imaging Reviews, Volume 12, Issue 3:

 

 

For details on the articles, please visit this link :: http://bit.ly/2a45X8L

Podcast: Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Kidney Disease

Author(s): Melissa Nataatmadja

For Journal details, visit: http://benthamscience.com/journals/reviews-on-recent-clinical-trials/#top

Subscribe to our YouTube channelhttp://bit.ly/1lr0czy 

Testimonial by Dr. Jijun Chen!

test 2

Dr. Jijun Chen

Contributed Article: “Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease”

Press Release for EurekAlert! Recent advances in site specific conjugations of antibody drug conjugates

Antibody-drug conjugates take the advantage of antigen specificity of monoclonal antibodies to deliver highly potent cytotoxic drugs selectively to antigen-expressing tumor cells.

The recent approval of Adcetris™ and Kadcyla™ as well as emerging data from numerous ongoing clinical trials underscore the role of antibody-drug conjugates (ADCs) as a new therapeutic option for cancer patients. The site-specific conjugation technologies to develop next-generation ADCs have grown rapidly since then and have proven to be robust platform for generating next-generation homogeneous ADCs. These homogeneous ADCs have exhibited superior properties in terms of stability, manufacturing, and therapeutic index over the conventional ADCs. Although most ADCs currently in clinical development rely on conventional conjugation chemistries, the first wave of site-specific ADCs has been promoted to clinical trials. The increased understanding from the clinical investigation of current ADCs and site-specific bio-conjugation technologies has enabled scientists to accelerate the discovery and development of the next generation ADCs with defined and homogeneous compositions. Ongoing efforts to improve conjugation technologies and understanding of structure-activity relationship will certainly broaden the role of ADCs and other conjugates for the treatment of cancer and potentially other immuno-mediated diseases.

Read the recently published research on “Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs)” from the journal Current Cancer Drug Targets”

Blog at WordPress.com. | The Baskerville Theme.

Up ↑

Follow

Get every new post delivered to your Inbox.

Join 6,744 other followers

%d bloggers like this: